BARCLAYS PLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$217
+4.8%
62,579
+40.7%
0.00%
Q2 2023$207
-63.0%
44,486
-63.3%
0.00%
Q1 2023$559
-15.4%
121,144
+47.9%
0.00%
Q4 2022$661
-99.4%
81,899
+300.9%
0.00%
Q3 2022$114,000
-8.8%
20,429
-14.3%
0.00%
Q2 2022$125,000
-71.7%
23,838
-55.5%
0.00%
Q1 2022$441,000
-95.8%
53,591
-92.4%
0.00%
-100.0%
Q4 2021$10,546,000
+68.8%
708,774
+114.4%
0.00%
-33.3%
Q3 2021$6,247,000
+40.6%
330,624
+38.3%
0.00%
+50.0%
Q2 2021$4,443,000
-24.9%
238,994
-8.1%
0.00%
-33.3%
Q1 2021$5,919,000
+18.5%
260,123
+13.0%
0.00%0.0%
Q4 2020$4,995,000
+107.9%
230,119
-3.8%
0.00%
+200.0%
Q3 2020$2,403,000
+30.5%
239,125
+0.7%
0.00%0.0%
Q2 2020$1,841,000
-21.5%
237,359
+3.2%
0.00%
-50.0%
Q1 2020$2,346,000
+1061.4%
229,941
+1156.6%
0.00%
Q4 2019$202,000
+74.1%
18,299
+43.7%
0.00%
Q3 2019$116,000
+4.5%
12,732
+30.9%
0.00%
Q2 2019$111,000
+428.6%
9,726
+438.5%
0.00%
Q1 2019$21,000
+133.3%
1,806
+80.8%
0.00%
Q4 2018$9,0009990.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders